TrialReader


The Therapeutic Effect of Dau-Di-Wu-Gong in Patient With Ankle Fracture

NCT03805347 — Phase 1 / Phase 2, Completed, 45 participants, Changhua Christian Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Therapeutic Effect of Helminthostachys Zeylanica(L.)Hook on Functional Recovery After Surgical Operation in Patients With Ankle Fracture

RegistryNCT03805347
StatusCompleted
PhasePhase 1 / Phase 2
Study typeInterventional; randomized, parallel, masking: triple, treatment
Enrollment45 (Actual)
SponsorChanghua Christian Hospital (Other)
ConditionsAnkle Fractures
InterventionsHelminthostachys zeylanica(L.)Hook, Starch (Drug)
Datesstart 2020-12-12, primary completion 2021-01-11, completion 2021-01-11, first posted 2019-01-15, last updated 2021-08-09
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Ankle Fractures All trials of Helminthostachys zeylanica(L.)Hook All trials of Starch

-Summary

Ankle fracture is one of most common bone fracture in Taiwan, although ankle fracture can be treated by surgical operation, local edema, pain and wound poor healing always is noted, according to the investigator's knowledge, no good therapeutic methods to treat mention-above symptoms until now. Helminthostachys zeylanica(L.)Hook, also called Dau-Di-U-Gon has anti-inflammation, calm down heat and detoxication, and anti-edema. People in Taiwan often uses Helminthostachys zeylanica(L.)Hook to treat bone and tendon pain, and its Ugonin component of Helminthostachys zeylanica(L.)Hook also is proved that has analgesia and ant-inflammation. Therefore, the purpose of the present study was to design a randomized, double-blind, controlled study to evaluate functional recovery effect of Helminthostachys zeylanica(L.)Hook after surgical operation in patients with ankle fracture.

Expand all sections  ·  Collapse all

+Detailed description

the purpose of the present study was to design a randomized, double-blind, controlled study to evaluate functional recovery effect of Helminthostachys zeylanica(L.)Hook after surgical operation in patients with ankle fracture. The primary outcome measure was the scores change of American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot scale, and tape (figure-of-eight) methods. Secondary outcome measure was the level changes of bone metabolism in peripheral blood, four diagnostic method, and the changes of ankle X-ray findings.

+Arms and interventions

ArmTypeInterventionsDescription
MedicationExperimentalDrug: Helminthostachys zeylanica(L.)HookExtract of Helminthostachys zeylanica(L.)Hook in capsule, 1gm/time, 3 times daily
StarchPlacebo comparatorDrug: StarchStarch in capsule,1gm/time, 3 times daily
  • Helminthostachys zeylanica(L.)Hook (Drug), also known as Dao-Di-Wu-Gong: Extract of Helminthostachys zeylanica(L.)Hook, 1gm/time, 3 times daily
  • Starch (Drug), also known as Placebo: Starch in capsule, 1gm/time, 3 times daily

+Outcome measures

Primary outcomes

  • Change of American Orthopedic Foot and Ankle(AOFAS) Score [1st day of study, 10~14th days of study, 43th days of study]: Score to evaluate ankle and hindfoot function, from 0-100 points, healthy ankle 100 points
  • Change of Ankle volume [1st day of study, 10~14th days of study, 43th days of study]: figure-of-8 method

Secondary outcomes

  • Level of bone turnover marker [1st day of study, 43th days of study]: Alkaline Phosphatase(ALP)normal range between 37 and 116 U/L; type 1 procollagen amino-terminal-propeptide (P1NP), normal range between 20-42 ng/L
  • Fracture Healing [1st day of study, 43th days of study]: ankle radiography, bone callus formation and continuity of callus

+Eligibility

Sex: All, ages: 20 Years to 75 Years

Inclusion Criteria:

* 20-75 year-old male or female with acute ankle fractures with surgical indication (Joint line displacement >2mm ; fracture dislocation)

Exclusion Criteria:

* Previous skin disease, DM or peripheral vessel disease with local foot amputation.
* Previous ankle surgery, old ankle fracture, or open fracture.
* Liver or renal dysfunction, and cardiorespiratory failure.
* Surgical infection after surgery.
* Patient refuse or can't finish the treatment course
* Patient with cancer
* Pregnancy
* HIV positive.

+Locations (1)

FacilityCityCountryStatus
ChangHua Christian HospitalChanghuaTaiwan

+Publications

  • Huang YL, Shen CC, Shen YC, Chiou WF, Chen CC. Anti-inflammatory and Antiosteoporosis Flavonoids from the Rhizomes of Helminthostachys zeylanica. J Nat Prod. 2017 Feb 24;80(2):246-253. doi: 10.1021/acs.jnatprod.5b01164. Epub 2017 Feb 7. PMID 28169537

+Investigators

My Notes